Pancreatic ductal adenocarcinoma and transcription factors: Role of c-Myc

被引:46
|
作者
Skoudy A. [1 ]
Hernández-Muñoz I. [1 ]
Navarro P. [1 ]
机构
[1] Cancer Research Programme, IMIM (Institut de Recerca Hospital Del Mar), Barcelona 08003
关键词
c-Myc; Ela-myc transgenic mouse; Pancreatic development; Pancreatic ductal adenocarcinoma; Transcription factor;
D O I
10.1007/s12029-011-9258-0
中图分类号
学科分类号
摘要
Introduction: Deregulated expression/activation of transcription factors is a key event in the establishment and progression of human cancer. Furthermore, most oncogenic signaling pathways converge on sets of transcription factors that ultimately control gene expression patterns resulting in cancer development, progression, and metastasis. Methods: Ductal pancreatic adenocarcinoma (PDA) is the main type of pancreatic cancer and the fourth leading cause of cancer mortality in the Western world. The early stage of the disease is characterized by pancreatic intraepithelial neoplasia lesions bearing mutations in the K-RAS proto-oncogene, which progress to malignant PDA by accumulating additional mutations in the tumor suppressor gene CDKN2A (p16) and in SMAD4 and TP53 transcription factors. The involvement of other signaling pathways in PDA development and progression is an active area of research which may help to clarify the critical steps of this devastating disease. Results: In this regard, several in vitro and in vivo data have demonstrated the contribution of the transcription factor c-Myc to pancreatic carcinogenesis although the molecular mechanisms are poorly understood. c-Myc is a proto-oncogene which has a pivotal function in growth control, differentiation and apoptosis and is known to act as a downstream transcriptional effector of many signaling pathways involved in these processes. It is regulated at multiple levels and its abnormal expression contributes to the genesis of many human tumors. Conclusions: This review focuses on the role of c-Myc in pancreatic embryonic development and homeostasis as well as its involvement on pancreatic tumorigenesis. Evidences showing that c-Myc function is highly dose and cell context dependent, together with its recently demonstrated ability to reprogram somatic cells towards a pluripotent stem cell-like state, indicate that the role of c-Myc in pancreas pathophysiology might have been previously underscored. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:76 / 84
页数:8
相关论文
共 50 条
  • [21] Positive and negative regulation of c-myc transcription
    Zou, X
    Lin, Y
    Rudchenko, S
    Calame, K
    C-MYC IN B-CELL NEOPLASIA: 14TH WORKSHOP ON MECHANISMS IN B-CELL NEOPLASIA, 1997, 224 : 57 - 66
  • [22] Direct activation of TERT transcription by c-MYC
    Wu, KJ
    Grandori, C
    Amacker, M
    Simon-Vermot, N
    Polack, A
    Lingner, J
    Dalla-Favera, R
    NATURE GENETICS, 1999, 21 (02) : 220 - 224
  • [23] Direct activation of TERT transcription by c-MYC
    Kou-Juey Wu
    Carla Grandori
    Mario Amacker
    Nathalie Simon-Vermot
    Axel Polack
    Joachim Lingner
    Riccardo Dalla-Favera
    Nature Genetics, 1999, 21 : 220 - 224
  • [24] INVITRO INHIBITION OF C-MYC TRANSCRIPTION BY MITHRAMYCIN
    HARDENBOL, P
    VANDYKE, MW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (02) : 553 - 558
  • [25] Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma
    Drexler, Richard
    Fahy, Rebecca
    Kuechler, Mirco
    Wagner, Kim C.
    Reese, Tim
    Ehmke, Mareike
    Feyerabend, Bernd
    Kleine, Moritz
    Oldhafer, Karl J.
    PANCREATOLOGY, 2021, 21 (01) : 170 - 179
  • [26] Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression
    Liu, Chengmin
    Jiang, Ke
    Ding, Yanyan
    Yang, Aihua
    Cai, Renwei
    Bai, Panzhu
    Xiong, Minggang
    Fu, Changying
    Quan, Meiling
    Xiong, Zailin
    Deng, Yi
    Tian, Ruijun
    Wu, Chuanyue
    Sun, Ying
    THERANOSTICS, 2023, 13 (13): : 4333 - 4355
  • [27] BMI-1 COOPERATES WITH C-MYC, SUPPRESSES TRANSCRIPTION AND ATTENUATES C-MYC INDUCED APOPTOSIS
    COHEN, KJ
    HANNA, JS
    DANG, CV
    BLOOD, 1994, 84 (10) : A374 - A374
  • [28] AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC
    Taira, T
    Maeda, J
    Onishi, T
    Kitaura, H
    Yoshida, S
    Kato, H
    Ikeda, M
    Tamai, K
    Iguchi-Ariga, SMM
    Ariga, H
    GENES TO CELLS, 1998, 3 (08) : 549 - 565
  • [29] Target c-Myc to treat pancreatic cancer
    Ala, Moein
    CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 34 - 50
  • [30] Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
    Ushio, Jun
    Kanno, Atsushi
    Ikeda, Eriko
    Ando, Kozue
    Nagai, Hiroki
    Miwata, Tetsurou
    Kawasaki, Yuki
    Tada, Yamato
    Yokoyama, Kensuke
    Numao, Norikatsu
    Tamada, Kiichi
    Lefor, Alan Kawarai
    Yamamoto, Hironori
    DIAGNOSTICS, 2021, 11 (03)